Abstract
In the field of thrombosis and haemostasis, many preanalytical variables influence the results of coagulation assays and measures to limit potential results variations should be taken. To our knowledge, no paper describing the development and maintenance of a haemostasis biobank has been previously published. Our description of the biobank of the Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+) is intended to facilitate the set-up of other biobanks in the field of thrombosis and haemostasis. SWITCO65+ is a multicentre cohort that prospectively enrolled consecutive patients aged ≥65 years with venous thromboembolism at nine Swiss hospitals from 09/2009 to 03/2012. Patients will be followed up until December 2013. The cohort includes a biobank with biological material from each participant taken at baseline and after 12 months of follow-up. Whole blood from all participants is assayed with a standard haematology panel, for which fresh samples are required. Two buffy coat vials, one PAXgene Blood RNA System tube and one EDTA-whole blood sample are also collected at baseline for RNA/DNA extraction. Blood samples are processed and vialed within 1 h of collection and transported in batches to a central laboratory where they are stored in ultra-low temperature archives. All analyses of the same type are performed in the same laboratory in batches. Using multiple core laboratories increased the speed of sample analyses and reduced storage time. After recruiting, processing and analyzing the blood of more than 1,000 patients, we determined that the adopted methods and technologies were fit-for-purpose and robust.
Similar content being viewed by others
References
Salvaterra E, Lecchi L, Giovanelli S, Butti B, Bardella MT, Bertazzi PA et al (2008) Banking together. A unified model of informed consent for biobanking. EMBO Rep 9:307–313
Riegman PH, Morente MM, Betsou F, de Blasio P, Geary P (2008) Biobanking for better healthcare. Mol Oncol 2:213–222
Field JK, Liloglou T, Niaz A, Bryan J, Gosney JR, Giles T et al (2009) EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration. Eur Respir J 34:1477–1486
Molnar MJ, Bencsik P (2006) Establishing a neurological-psychiatric biobank: banking, informatics, ethics. Cell Immunol 244:101–104
Jayasinghe SR, Mishra A, Van Daal A, Kwan E (2009) Genetics and cardiovascular disease: design and development of a DNA biobank. Exp Clin Cardiol 14:33–37
Schrohl AS, Wurtz S, Kohn E, Banks RE, Nielsen HJ, Sweep FC et al (2008) Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics 7:2061–2066
Méan M, Righini M, Jaeger K, Beer HJ, Frauchiger B, Osterwalder J et al (2013) The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology. J Thromb Thrombolysis
Sudore RL, Landefeld CS, Williams BA, Barnes DE, Lindquist K, Schillinger D (2006) Use of a modified informed consent process among vulnerable patients: a descriptive study. J Gen Intern Med 21:867–873
Sugarman J, McCrory DC, Hubal RC (1998) Getting meaningful informed consent from older adults: a structured literature review of empirical research. J Am Geriatr Soc 46:517–524
Flory J, Emanuel E (2004) Interventions to improve research participants’ understanding in informed consent for research: a systematic review. JAMA 292:1593–1601
Mello MM, Wolf LE (2010) The Havasupai Indian tribe case–lessons for research involving stored biologic samples. N Engl J Med 363:204–207
Adcock DM, Hoefner DM, Kottke-Marchant K, Marlar RA, Szamosi DI, Warunek DI (2008) Collection, transport and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays: approved guideline, 5th edn. Clinical and Laboratory Standards Institute, Wayne, PA
Favaloro EJ, Lippi G, Adcock DM (2008) Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost 34:612–634
Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC (2006) Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis 17:513–519
Snyder SR, Favoretto AM, Derzon JH, Christenson RH, Kahn SE, Shaw CS et al (2012) Effectiveness of barcoding for reducing patient specimen and laboratory testing identification errors: a Laboratory Medicine Best Practices systematic review and meta-analysis. Clin Biochem 45:988–998
Sédille-Mostafaie N, Engler H, Lutz S, Korte W (2012) Advancing haemostasis automation—successful implementation of robotic centrifugation and sample processing in a tertiary service hospital. Clin Chem Lab Med 15:1–6
Lippi G, Salvagno GL, Montagnana M, Manzato F, Guidi GC (2007) Influence of the centrifuge time of primary plasma tubes on routine coagulation testing. Blood Coagul Fibrinolysis 18:525–528
Sultan A (2010) Five-minute preparation of platelet-poor plasma for routine coagulation testing. East Mediterr Health J 16:233–236
Favaloro EJ, Funk DM, Lippi G (2012) Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab Med 43:1–10
Ostroff R, Foreman T, Keeney TR, Stratford S, Walker JJ, Zichi D (2010) The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. J Proteomics 73:649–666
Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L (2008) Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 99:416–426
Dargaud Y, Negrier C (2010) Thrombin generation testing in haemophilia comprehensive care centres. Haemophilia 16:223–230
Woodhams B, Girardot O, Blanco MJ, Colesse G, Gourmelin Y (2001) Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 12:229–236
Rundle AG, Vineis P, Ahsan H (2005) Design options for molecular epidemiology research within cohort studies. Cancer Epidemiol Biomarkers Prev 14:1899–1907
Paltiel L, Ronningen KS, Meltzer HM, Baker SV, Hoppin JA (2008) Evaluation of freeze thaw cycles on stored plasma in the Biobank of the Norwegian mother and child cohort study. Cell Preserv Technol 6:223–230
Larsen TB, Sorensen HT, Skytthe A, Johnsen SP, Vaupel JW, Christensen K (2003) Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology 14:328–332
Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM et al (2000) Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic analysis of idiopathic thrombophilia. Am J Hum Genet 67:1452–1459
Tregouet DA, Heath S, Saut N, Biron-Andreani C, Schved JF, Pernod G et al (2009) Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 113:5298–5303
Rasmussen-Torvik LJ, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Rosamond WD et al (2007) The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res 121:1–7
McMurdo ME, Roberts H, Parker S, Wyatt N, May H, Goodman C et al (2011) Improving recruitment of older people to research through good practice. Age Ageing 40:659–665
Acknowledgments
This cohort study is supported by the Swiss National Science Foundation (Grant no. 33CSO-122659/139470). We thank Kali Tal, Ph.D. for her editorial work.
Conflict of interest
The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Méan, M., Aujesky, D., Lämmle, B. et al. Design and establishment of a biobank in a multicenter prospective cohort study of elderly patients with venous thromboembolism (SWITCO65+) . J Thromb Thrombolysis 36, 484–491 (2013). https://doi.org/10.1007/s11239-013-0922-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-013-0922-z